New update to Candidate List of Substances of Very High Concern (SVHCs)
Europe
New update to Candidate List of Substances of Very High Concern (SVHCs)
On 7th November 2024, the ECHA (European Chemicals Agency) released the new Candidate List of SVHCs with the addition of one new substance. The current list of SVHCs now contains 242 substances.
See below a table indicating the latest substance addition:
Legal obligations for companies using SVHC substances include:
- Suppliers provide customers and consumers with enough information to allow for safe use of products that contain a substance of very high concern (SVHC) above a concentration of 0.1 % (weight by weight)
- Importers and producers of these products must notify the ECHA if their article contains SVHC substances above a concentration of 0.1% weight by weight (w/w) and the substance is present in those products in quantities totalling over 1 tonne per producer or per importer per year. The notifications must be submitted within six months from the date it that the substance is included in the list.
- Suppliers of substances on the Candidate List, supplied either on their own or in mixtures, must provide their customers with a safety data sheet.
- Under the Waste Framework Directive (Directive 2008/98/EC on waste- WFD), any supplier of an article containing a substance of very high concern (SVHC) in a concentration above 0.1% weight by weight (w/w) on the EU market is required to submit a SCIP Notification on that article to ECHA, as of 5 January 2021. SCIP is the database holding information on Substances of Concern in articles, as such or in complex objects (products), established under the WFD. The SCIP database complements the existing notification obligations for Candidate List substances in articles subject to REACH regulation and its related communication through the supply chain, according to Articles 7 (2) and 33 respectively.
Please click this link to read more:https://echa.europa.eu/candidate-list-table
NOUS RECOMMANDONS
Articles connexes
- Abonnez-vous à MedInsights
- Abonnez-vous à MedInsights
- Abonnez-vous à MedInsights
- Abonnez-vous à MedInsights
- Abonnez-vous à MedInsights